Abstract: A memory controller includes, in one embodiment, a memory interface and a controller circuit. The memory interface is configured to interface with a memory having a plurality of wordlines. The controller circuit is configured to program, with foggy-fine programming, a first portion of the plurality of wordlines to store first program data, program, with the foggy-fine programming, one or more wordlines of the plurality of wordlines in a non-fine state, the one or more wordlines neighboring the first portion, and program, with the foggy-fine programming, a second portion of the plurality of wordlines to store second program data, the second portion neighboring the one or more wordlines.

Abstract: A memory controller includes, in one embodiment, a memory interface and a controller circuit. The memory interface is configured to interface with a memory having a plurality of wordlines. The controller circuit is configured to program, with foggy-fine programming, a first portion of the plurality of wordlines to store first program data, program, with the foggy-fine programming, one or more wordlines of the plurality of wordlines in a non-fine state, the one or more wordlines neighboring the first portion, and program, with the foggy-fine programming, a second portion of the plurality of wordlines to store second program data, the second portion neighboring the one or more wordlines.

Abstract: The present invention relates to a pharmaceutical combination for use in the treatment of squamous cell carcinoma, comprising a CDK inhibitor selected from the compounds of formula (I); or a pharmaceutically acceptable salt thereof and one or more antineoplastic agents selected from sorafenib, lapatinib, erlotinib, cisplatin, 5-fluorouracil, docetaxel or cetuximab or a pharmaceutically acceptable salt thereof. The said pharmaceutical combination exhibits synergy when used in the treatment of squamous cell carcinoma of head and neck (SCCHN). The invention also relates to a pharmaceutical composition comprising the said combination and a method for the treatment of squamous cell carcinoma of head and neck (SCCHN), using a therapeutically effective amount of said combination.

Abstract: The present invention relates to a pharmaceutical combination for use in the treatment of squamous cell carcinoma, comprising a CDK inhibitor selected from the compounds of formula (I); or a pharmaceutically acceptable salt thereof and one or more antineoplastic agents selected from sorafenib, lapatinib, erlotinib, cisplatin, 5-fluorouracil, docetaxel or cetuximab or a pharmaceutically acceptable salt thereof. The said pharmaceutical combination exhibits synergy when used in the treatment of squamous cell carcinoma of head and neck (SCCHN). The invention also relates to a pharmaceutical composition comprising the said combination and a method for the treatment of squamous cell carcinoma of head and neck (SCCHN), using a therapeutically effective amount of said combination.

Abstract: The present invention relates to a pharmaceutical combination for use in the treatment of squamous cell carcinoma, comprising a CDK inhibitor selected from the compounds of formula (I); or a pharmaceutically acceptable salt thereof and one or more antineoplastic agents selected from sorafenib, lapatinib, erlotinib, cisplatin, 5-fluorouracil, docetaxel or cetuximab or a pharmaceutically acceptable salt thereof. The said pharmaceutical combination exhibits synergy when used in the treatment of squamous cell carcinoma of head and neck (SCCHN). The invention also relates to a pharmaceutical composition comprising the said combination and a method for the treatment of squamous cell carcinoma of head and neck (SCCHN), using a therapeutically effective amount of said combination.

Abstract: The present invention relates to a pharmaceutical combination for use in the treatment of squamous cell carcinoma, comprising a CDK inhibitor selected from the compounds of formula (I); or a pharmaceutically acceptable salt thereof and one or more antineoplastic agents selected from sorafenib, lapatinib, erlotinib, cisplatin, 5-fluorouracil, docetaxel or cetuximab or a pharmaceutically acceptable salt thereof. The said pharmaceutical combination exhibits synergy when used in the treatment of squamous cell carcinoma of head and neck (SCCHN). The invention also relates to a pharmaceutical composition comprising the said combination and a method for the treatment of squamous cell carcinoma of head and neck (SCCHN), using a therapeutically effective amount of said combination.

Abstract: Aspects of the disclosure are related to a method for installing one or more filtering rules, comprising: receiving the filtering rules; and installing the filtering rules into a mobile network modem, in which each filtering rule may be associated with a layer of an over-the-air (OTA) protocol stack and specifies a type of payload and one or more conditions for the payload.

Abstract: The present invention relates to a pharmaceutical combination for use in the treatment of squamous cell carcinoma, comprising a CDK inhibitor selected from the compounds of formula (I); or a pharmaceutically acceptable salt thereof and one or more antineoplastic agents selected from sorafenib, lapatinib, erlotinib, cisplatin, 5-fluorouracil, docetaxel or cetuximab or a pharmaceutically acceptable salt thereof. The said pharmaceutical combination exhibits synergy when used in the treatment of squamous cell carcinoma of head and neck (SCCHN). The invention also relates to a pharmaceutical composition comprising the said combination and a method for the treatment of squamous cell carcinoma of head and neck (SCCHN), using a therapeutically effective amount of said combination.

Abstract: Methods, devices, and systems for detecting return-oriented programming (ROP) exploits are disclosed. A system includes a processor, a main memory, and a cache memory. A cache monitor develops an instruction loading profile by monitoring accesses to cached instructions found in the cache memory and misses to instructions not currently in the cache memory. A remedial action unit terminates execution of one or more of the valid code sequences if the instruction loading profile is indicative of execution of an ROP exploit involving one or more valid code sequences. The instruction loading profile may be a hit/miss ratio derived from monitoring cache hits relative to cache misses. The ROP exploits may include code snippets that each include an executable instruction and a return instruction from valid code sequences.

Abstract: Disclosed is an apparatus and method to perform a pairing process with a limited input wireless device. A host device includes a transceiver and a processor. The processor may be configured to execute instructions to: receive from the transceiver a pairing process request from the limited input wireless device, wherein the pairing process request includes a private code based upon a physical user action implemented with the limited input wireless device; and implement a pairing process to validate the limited input wireless device for a particular host device function associated with the private code.

Abstract: To inhibit cross-site forgery attacks, different types/classes of cookies are used. A first cookie and a second cookie are generated by a web server and provided to a client browser during a web session. The first cookie defines a first set of use conditions for when the first cookie is to be used within the web session. The second cookie defines a second set of use conditions for when the second cookie is to be used within the web session. The client browser determines which (if any) of the first cookie or second cookie to send to the web server based on the use conditions defined within each cookie and the operation(s) sought by the client browser. The web server may grant different or the same privileges to operation(s) being sought by the client browser depending on whether the first or second cookie is sent by the client browser.

Abstract: Methods, devices, and systems for detecting return-oriented programming (ROP) exploits are disclosed. A system includes a processor, a main memory, and a cache memory. A cache monitor develops an instruction loading profile by monitoring accesses to cached instructions found in the cache memory and misses to instructions not currently in the cache memory. A remedial action unit terminates execution of one or more of the valid code sequences if the instruction loading profile is indicative of execution of an ROP exploit involving one or more valid code sequences. The instruction loading profile may be a hit/miss ratio derived from monitoring cache hits relative to cache misses. The ROP exploits may include code snippets that each include an executable instruction and a return instruction from valid code sequences.

Abstract: Methods, devices, and systems for detecting return-oriented programming (ROP) exploits are disclosed. A system includes a processor, a main memory, and a cache memory. A cache monitor develops an instruction loading profile by monitoring accesses to cached instructions found in the cache memory and misses to instructions not currently in the cache memory. A remedial action unit terminates execution of one or more of the valid code sequences if the instruction loading profile is indicative of execution of an ROP exploit involving one or more valid code sequences. The instruction loading profile may be a hit/miss ratio derived from monitoring cache hits relative to cache misses. The ROP exploits may include code snippets that each include an executable instruction and a return instruction from valid code sequences.

Abstract: A method, apparatus, and/or system for execution prevention is provided. A state indicator for a first subset of a plurality of memory pages of executable code in a memory device is set to a non-executable state. A state indicator for a second subset of the plurality of memory pages is set to an executable state, where the second subset of the plurality of memory pages includes indirection stubs to functions in the first subset of the plurality of memory pages. Upon execution of an application, a function call is directed to a corresponding indirection stub in the second subset of the plurality of memory pages which modifies the state indicator for a corresponding function in the first subset of the plurality of memory pages prior to directing execution of the called function from the first subset of the plurality of memory pages.

Abstract: Disclosed is an apparatus and method to detect vehicle theft. In one embodiment, a processor may be configured to execute instructions to: receive a vehicle detection signal from a vehicle detector; determine whether a vehicle is present or absent based upon the vehicle detection signal; establish an authentication credential after the vehicle is determined to present; and validate the authentication credential to indicate validated parking. If the vehicle is determined to be absent and an authentication credential to un-park the vehicle has not been validated, a notification action may be transmitted to appropriate personnel to indicate that the vehicle has been moved or un-parked without proper authentication.

Abstract: The present invention relates to a pharmaceutical combination for use in the treatment of squamous cell carcinoma, comprising a CDK inhibitor selected from the compounds of formula (I); or a pharmaceutically acceptable salt thereof and one or more antineoplastic agents selected from sorafenib, lapatinib, erlotinib, cisplatin, 5-fluorouracil, docetaxel or cetuximab or a pharmaceutically acceptable salt thereof. The said pharmaceutical combination exhibits synergy when used in the treatment of squamous cell carcinoma of head and neck (SCCHN). The invention also relates to a pharmaceutical composition comprising the said combination and a method for the treatment of squamous cell carcinoma of head and neck (SCCHN), using a therapeutically effective amount of said combination.

Abstract: A method, apparatus, and/or system for execution prevention is provided. A state indicator for a first subset of a plurality of memory pages of executable code in a memory device is set to a non-executable state. A state indicator for a second subset of the plurality of memory pages is set to an executable state, where the second subset of the plurality of memory pages includes indirection stubs to functions in the first subset of the plurality of memory pages. Upon execution of an application, a function call is directed to a corresponding indirection stub in the second subset of the plurality of memory pages which modifies the state indicator for a corresponding function in the first subset of the plurality of memory pages prior to directing execution of the called function from the first subset of the plurality of memory pages.

Abstract: To inhibit cross-site forgery attacks, different types/classes of cookies are used. A first cookie and a second cookie are generated by a web server and provided to a client browser during a web session. The first cookie defines a first set of use conditions for when the first cookie is to be used within the web session. The second cookie defines a second set of use conditions for when the second cookie is to be used within the web session. The client browser determines which (if any) of the first cookie or second cookie to send to the web server based on the use conditions defined within each cookie and the operation(s) sought by the client browser. The web server may grant different or the same privileges to operation(s) being sought by the client browser depending on whether the first or second cookie is sent by the client browser.

Abstract: Disclosed is an apparatus and method to perform a pairing process with a limited input wireless device. A host device includes a transceiver and a processor. The processor may be configured to execute instructions to: receive from the transceiver a pairing process request from the limited input wireless device, wherein the pairing process request includes a private code based upon a physical user action implemented with the limited input wireless device; and implement a pairing process to validate the limited input wireless device for a particular host device function associated with the private code.

Abstract: Disclosed is an apparatus and method to detect vehicle theft. In one embodiment, a processor may be configured to execute instructions to: receive a vehicle detection signal from a vehicle detector; determine whether a vehicle is present or absent based upon the vehicle detection signal; establish an authentication credential after the vehicle is determined to present; and validate the authentication credential to indicate validated parking. If the vehicle is determined to be absent and an authentication credential to un-park the vehicle has not been validated, a notification action may be transmitted to appropriate personnel to indicate that the vehicle has been moved or un-parked without proper authentication.